BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24716976)

  • 61. Crucial role of TSC-22 in preventing the proteasomal degradation of p53 in cervical cancer.
    Yoon CH; Rho SB; Kim ST; Kho S; Park J; Jang IS; Woo S; Kim SS; Lee JH; Lee SH
    PLoS One; 2012; 7(8):e42006. PubMed ID: 22870275
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells.
    Kitamura S; Miyazaki Y; Shinomura Y; Kondo S; Kanayama S; Matsuzawa Y
    Jpn J Cancer Res; 1999 Jan; 90(1):75-80. PubMed ID: 10076568
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Troglitazone inhibits isolated cell proliferation, and induces apoptosis in isolated rat mesangial cells.
    Tsuchiya T; Shimizu H; Shimomura K; Mori M
    Am J Nephrol; 2003; 23(4):222-8. PubMed ID: 12840598
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Peroxisome proliferator-actived receptor-gamma ligand troglitazone induces apoptosis in renal cell carcinoma].
    Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu XQ; Liu WJ; Guo YL; Wu JP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 36(2):173-6. PubMed ID: 15100737
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The PPARγ agonist Troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells.
    Yan S; Yang X; Chen T; Xi Z; Jiang X
    Cancer Gene Ther; 2014 May; 21(5):188-93. PubMed ID: 24853624
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
    Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
    Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Troglitazone sensitizes effect of epirubicin on breast cancer cells].
    Sun JX; Meng ZX; Lv JH; Sun YJ
    Ai Zheng; 2006 Aug; 25(8):960-6. PubMed ID: 16965675
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The peroxisome proliferator-activated receptor-gamma agonist troglitazone inhibits transforming growth factor-beta-mediated glioma cell migration and brain invasion.
    Coras R; Hölsken A; Seufert S; Hauke J; Eyüpoglu IY; Reichel M; Tränkle C; Siebzehnrübl FA; Buslei R; Blümcke I; Hahnen E
    Mol Cancer Ther; 2007 Jun; 6(6):1745-54. PubMed ID: 17541035
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Troglitazone induced apoptosis via PPARγ activated POX-induced ROS formation in HT29 cells.
    Wang J; Lv X; Shi J; Hu X; DU Y
    Biomed Environ Sci; 2011 Aug; 24(4):391-9. PubMed ID: 22108328
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Troglitazone suppresses glutamine metabolism through a PPAR-independent mechanism.
    Reynolds MR; Clem BF
    Biol Chem; 2015 Aug; 396(8):937-47. PubMed ID: 25872876
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Ligand for peroxisome proliferator-activated receptor gamma inhibits human cholangiocarcinoma cell growth: potential molecular targeting strategy for cholangioma.
    Kobuke T; Tazuma S; Hyogo H; Chayama K
    Dig Dis Sci; 2006 Sep; 51(9):1650-7. PubMed ID: 16927143
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Autophagy augmented by troglitazone is independent of EGFR transactivation and correlated with AMP-activated protein kinase signaling.
    Yan J; Yang H; Wang G; Sun L; Zhou Y; Guo Y; Xi Z; Jiang X
    Autophagy; 2010 Jan; 6(1):67-73. PubMed ID: 19923924
    [TBL] [Abstract][Full Text] [Related]  

  • 73. PPARgamma activation extinguishes smoking carcinogen by inhibiting NNK-mediated proliferation.
    Li MY; Hsin MK; Yip J; Mok TS; Underwood MJ; Chen GG
    Am J Respir Cell Mol Biol; 2010 Jan; 42(1):113-22. PubMed ID: 19346318
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Carbon monoxide (from CORM-2) inhibits high glucose-induced ICAM-1 expression via AMP-activated protein kinase and PPAR-gamma activations in endothelial cells.
    Nizamutdinova IT; Kim YM; Kim HJ; Seo HG; Lee JH; Chang KC
    Atherosclerosis; 2009 Dec; 207(2):405-11. PubMed ID: 19524923
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism].
    Zhang M; Zou P; Bai M; Tao XN; Jin Y; Guo R
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1169-72. PubMed ID: 12921638
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway.
    Xiao Y; Yuan T; Yao W; Liao K
    FEBS J; 2010 Feb; 277(3):687-96. PubMed ID: 20050918
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Troglitazone induces G1 arrest by p27(Kip1) induction that is mediated by inhibition of proteasome in human gastric cancer cells.
    Takeuchi S; Okumura T; Motomura W; Nagamine M; Takahashi N; Kohgo Y
    Jpn J Cancer Res; 2002 Jul; 93(7):774-82. PubMed ID: 12149143
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
    Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
    Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Troglitazone and 9cis,11trans,13trans-conjugated linolenic acid: comparison of their antiproliferative and apoptosis-inducing effects on different colon cancer cell lines.
    Yasui Y; Hosokawa M; Kohno H; Tanaka T; Miyashita K
    Chemotherapy; 2006; 52(5):220-5. PubMed ID: 16899971
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Troglitazone inhibits endothelial cell proliferation through suppression of casein kinase 2 activity.
    Lee KS; Park JH; Lee S; Lim HJ; Jang Y; Park HY
    Biochem Biophys Res Commun; 2006 Jul; 346(1):83-8. PubMed ID: 16759638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.